Current status of the clinical and immunologic consequences of a prototype allergic disease prevention program
Hamburger, R.N.; Heller, S.; Mellon, M.H.; O'Connor, R.D.; Zeiger, R.S.
Annals of Allergy 51(2 Pt 2): 281-290
1983
ISSN/ISBN: 0003-4738 PMID: 6881617 Document Number: 219727
Document emailed within 1 workday
Related Documents
Kihara, M.; Tajima, K.; Tomizawa, I.; Ozaki, S.; Soda, K. 1995: Current status of HIV epidemic and prevention and control program in Cambodia Japanese Journal of Public Health 42(1): 44-49Hedfors, E. 1987: Rheumatic immunology--status of current research. Clinical consequences today and in the near future Lakartidningen 84(51): 4340-4342
Afonina, L.G. 1978: Current status of the problem of child immunity. IV. Immunologic mechanisms of hemolytic disease of the newborn infant Meditsinskaia Sestra 37(8): 6-10
Aas, K. 1970: Non-specific (non-immunologic) factors in allergic disease Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(6): 559-564
Nakayama, T. 1972: Consequences of medical specialization--current status and the problems Nursing Technique 18(10): 77-83
Kossovsky, N.; Freiman, C.J. 1994: Silicone breast implant pathology. Clinical data and immunologic consequences Archives of Pathology and Laboratory Medicine 118(7): 686-693
Kim, Y.H.; Park, C.-S.; Jang, T.Y. 2012: Immunologic properties and clinical features of local allergic rhinitis Journal of Otolaryngology - Head and Neck Surgery 41(1): 51-57
Boudes, P.; André, C. 1990: Wegener's disease. Current immunologic data and therapeutic implications Presse Medicale 19(12): 547-548
Boerr, L.A.; Morales, V.H.; Bai, J.C.; Gándara, M.A.; Barbatti, A.; Fink, N.; Morán, C.E.; Higa, R.A. 1982: Celiac disease, histocompatibility antigens and immunologic status Acta Gastroenterologica Latinoamericana 12(4): 333-349
Gorstein, J.; Shreshtra, R.K.; Pandey, S.; Adhikari, R.K.; Pradhan, A. 2003: Current status of vitamin A deficiency and the National Vitamin A Control Program in Nepal: results of the 1998 National Micronutrient Status Survey Asia Pacific Journal of Clinical Nutrition 12(1): 96-103
Berezhnaia, N.M.; Beĭko, V.A.; Evseeva, T.A. 1980: Immunologic mechanisms of specific hyposensitization in allergic diseases of an infectious nature. III. Immunologic processes in hyposensitization with microbial allergens Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 12: 78-83
Soothill, J.F. 1984: Prevention of food allergic disease Annals of Allergy 53(6 Pt 2): 689-691
Zi, W.L. 1996: Current status of the prevention and treatment of measles Zhonghua Liu Xing Bing Xue Za Zhi 17(2): 111-112
Ayisi, N.K. 1995: Differential cytopathicity and susceptibility of Ghanaian highly divergent HIV-2 -GH2-, prototype HIV-2 -GH1-, and prototype HIV-1 -GH3- to inhibition by dd Cyd and ddIno East African Medical Journal 72(10): 654-657
Gerok, W. 1992: Primary prevention of varicose bleeding: current status Schweizerische Rundschau für Medizin Praxis 81(24): 804-805
Reiser, H.; Rothenbuchner, G.; Schmidt, K.J.; St Labouvie 1983: Iodine deficiency--clinical consequences and possibilities for prevention Die Medizinische Welt 34(40): 1105-1108
Douglass, J.A.; O'Hehir, R.E. 2006: 1. Diagnosis, treatment and prevention of allergic disease: the basics Medical Journal of Australia 185(4): 228-233
Novák, J. 1988: The program for primary prevention and secondary prevention of ischemic coronary disease and research at the Laboratory of Human Energy Resources of the University of Wyoming in Laramie Casopis Lekaru Ceskych 127(37-38): 1190-1192
Lundberg, P.O. 2001: Still a small problem with the mad cow disease? Creutzfeldt-Jakob disease and other prion diseases: current status Lakartidningen 98(1-2): 19-24
Nuttall, J. 2010: Microbicides in the prevention of HIV infection: current status and future directions Drugs 70(10): 1231-1243